GlassScriptPhysician profile
Libby Y Kot
NPI 1962516641
$1,275.17
in general payments reported to CMS, 2019-2025
21 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $69.62 · 2021: $196 · 2022: $94.67 · 2023: $331 · 2024: $189 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $218.58 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Abbvie INC. | $212.95 | 2019-2022 | |
| Astellas Pharma US INC | $212.80 | 2021-2025 | Veozah, Myrbetriq |
| Myriad Women'S Health, INC. | $174.90 | 2023 | Myrisk |
| Organon LLC | $55.57 | 2022-2024 | Jada System |
| Coopersurgical, INC. | $53.85 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $43.21 | 2019-2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $43.19 | 2019-2025 | |
| Ethicon US, LLC | $32.81 | 2019 | |
| Sage Therapeutics, LLC | $31.32 | 2023-2025 | Zurzuvae |
| Lupin INC. | $26.65 | 2019 | |
| Pfizer INC. | $23.77 | 2019-2021 | |
| Agile Therapeutics, INC. | $23.44 | 2022 | |
| Daiichi Sankyo INC. | $17.38 | 2024 | Injectafer |
| Baxter Healthcare | $17.31 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $16.27 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.22 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $15.34 | 2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $14.95 | 2021 | |
| Boston Scientific Corporation | $14.63 | 2019 | |
| Meditrina | $10.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Libby Kot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.